Global Drug Screening Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application

Market Analysis and Insights: Global Drug Screening Market
In 2020, the global Drug Screening market size was US$ 4205.5 million and it is expected to reach US$ 6333.1 million by the end of 2027, with a CAGR of 5.6% between 2021 and 2027
Global Drug Screening Scope and Market Size
The global Drug Screening market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Drug Screening market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.

Segment by Type
Immunoassay Analyzers
Chromatography
Breath Analyzers
Rapid Testing Devices
Assay Kits and Reagents

Segment by Application
Hospitals
Research Institute
Biotechnology & Pharmaceutical Companies
Others

By Company
Abbott
Express Diagnostics
Laboratory Corporation of America
MPD
Quest Diagnostics
Roche Diagnostics
Shimadzu
Siemens Healthcare
Thermo Fisher Scientific

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Details
QYR-18445470

03-Jun-2021

111
License